| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
OPK
Opko Health
|
Jun 17, 2026 | BUY |
Strong Buy
+374.3% avg upside
12 analysts
|
$3.00
112.84% Upside
|
· |
|
LEGN
Legend Biotech
|
Jun 15, 2026 | BUY |
Strong Buy
+134.2% avg upside
27 analysts
|
$64.00
90.84% Upside
|
· |
|
NXTC
NextCure
|
Jun 10, 2026 | BUY |
Buy
+753.8% avg upside
10 analysts
|
$15.00
581.79% Upside
|
· |
|
FATE
Fate Therapeutics
|
Jun 09, 2026 | BUY |
Buy
+492.3% avg upside
31 analysts
|
$6.00
206.06% Upside
|
· |
|
IPSC
Century Therapeutics
|
Jun 09, 2026 | BUY |
Strong Buy
+132.9% avg upside
11 analysts
|
$4.00
77.80% Upside
|
+4.5% |
|
BMEA
Biomea Fusion
|
Jun 09, 2026 | BUY |
Strong Buy
+1034.7% avg upside
15 analysts
|
$7.00
483.43% Upside
|
· |
|
ARVN
Arvinas Holding Company
|
Jun 03, 2026 | BUY |
Buy
+265.4% avg upside
27 analysts
|
$20.00
160.78% Upside
|
-1.6% |
|
FULC
Fulcrum Therapeutics
|
Jun 02, 2026 | SELL |
Hold
+138.8% avg upside
13 analysts
|
$3.00
14.25% Downside
|
· |
|
IBRX
ImmunityBio
|
Jun 01, 2026 | BUY |
Strong Buy
+55.2% avg upside
12 analysts
|
$12.00
71.62% Upside
|
· |
|
INO
Inovio Pharmaceuticals
|
May 22, 2026 | BUY |
Buy
+808.5% avg upside
19 analysts
|
$6.00
440.60% Upside
|
-18.5% |
|
CAMP
CAMP4 Therapeutics Corporation
|
May 15, 2026 | BUY |
Strong Buy
+131.4% avg upside
9 analysts
|
$12.00
189.95% Upside
|
+3.2% |
|
CRDF
Cardiff Oncology
|
May 15, 2026 | BUY |
Strong Buy
+736.8% avg upside
18 analysts
|
$6.00
408.57% Upside
|
+0.0% |
|
DYN
Dyne Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
+93.5% avg upside
29 analysts
|
$45.00
134.40% Upside
|
+8.3% |
|
MIST
Milestone Pharmaceuticals
|
May 14, 2026 | BUY |
Strong Buy
+536.3% avg upside
7 analysts
|
$7.00
434.41% Upside
|
-10.1% |
|
CAPR
Capricor Therapeutics
|
May 13, 2026 | BUY |
Strong Buy
+68.4% avg upside
12 analysts
|
$58.00
107.45% Upside
|
-5.1% |
|
SKYE
Skye Bioscience
|
May 12, 2026 | BUY |
Strong Buy
+1336.8% avg upside
9 analysts
|
$6.00
743.33% Upside
|
+0.0% |
|
XNCR
Xencor
|
May 08, 2026 | BUY |
Strong Buy
+159.5% avg upside
27 analysts
|
$33.00
158.29% Upside
|
-12.4% |
|
GENB
Generate Biomedicines, Inc.
|
May 08, 2026 | BUY |
Strong Buy
+76.8% avg upside
6 analysts
|
$24.00
72.98% Upside
|
· |
|
GLUE
Monte Rosa Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+27.3% avg upside
14 analysts
|
$37.00
101.05% Upside
|
-5.6% |
|
MRNA
Moderna
|
May 08, 2026 | BUY |
Hold
+6.4% avg upside
38 analysts
|
$69.00
11.64% Upside
|
+17.7% |
|
CTMX
CytomX Therapeutics
|
May 08, 2026 | BUY |
Strong Buy
+269.4% avg upside
21 analysts
|
$12.00
305.39% Upside
|
-24.4% |
|
ARWR
Arrowhead Pharmaceuticals
|
May 08, 2026 | BUY |
Strong Buy
-19.1% avg upside
26 analysts
|
$110.00
35.67% Upside
|
+2.5% |
|
CRSP
Crispr Therapeutics AG
|
May 05, 2026 | BUY |
Buy
+39.7% avg upside
41 analysts
|
$110.00
107.29% Upside
|
-0.7% |
|
ALNY
Alnylam Pharma
|
May 01, 2026 | BUY |
Strong Buy
+23.4% avg upside
51 analysts
|
$489.00
72.99% Upside
|
-4.5% |
|
KPTI
Karyopharm Therapeutics
|
Apr 27, 2026 | BUY |
Strong Buy
+146.1% avg upside
18 analysts
|
$16.00
70.18% Upside
|
-11.4% |
|
MESO
Mesoblast
|
Apr 10, 2026 | BUY |
Strong Buy
+73.3% avg upside
14 analysts
|
$35.00
150.44% Upside
|
-1.4% |
|
ACRV
Acrivon Therapeutics, Inc.
|
Mar 02, 2026 | BUY |
Strong Buy
+818.9% avg upside
13 analysts
|
$8.00
426.26% Upside
|
+15.7% |
|
MCRB
Seres Therapeutics
|
Feb 13, 2026 | HOLD |
Buy
+163.4% avg upside
10 analysts
|
$20.00
209.63% Upside
|
-10.4% |
|
KYMR
Kymera Therapeutics
|
Dec 09, 2025 | BUY |
Strong Buy
+9.0% avg upside
36 analysts
|
$125.00
39.03% Upside
|
+3.5% |
|
STRO
Sutro Biopharma
|
Dec 04, 2025 | BUY |
Strong Buy
+31.8% avg upside
20 analysts
|
$20.00
29.63% Downside
|
+207.0% |
|
CUE
Cue Biopharma
|
Apr 01, 2025 | BUY |
Strong Buy
-66.0% avg upside
9 analysts
|
$2.00
92.48% Downside
|
-72.9% |
|
TPST
Tempest Therapeutics
|
Mar 28, 2025 | BUY |
Buy
+1662.1% avg upside
18 analysts
|
$65.00
5100.01% Upside
|
-82.8% |
|
XFOR
X4 Pharmaceuticals
|
Feb 07, 2025 | BUY |
Strong Buy
+496.4% avg upside
15 analysts
|
$60.00
1381.52% Upside
|
-77.6% |
|
SYRS
Syros Pharmaceuticals
|
Oct 23, 2024 | BUY |
Buy
+10812400.0% avg upside
9 analysts
|
$5.00
1249900.01% Upside
|
-100.0% |
|
TSE:APS
Aptose Biosciences
|
Apr 03, 2024 | BUY |
Strong Buy
+4059.2% avg upside
10 analysts
|
$209.96
9443.38% Upside
|
· |
|
BCYC
Bicycle Therapeutics
|
Nov 03, 2023 | BUY |
Strong Buy
+504.5% avg upside
20 analysts
|
$52.00
1187.08% Upside
|
+46.2% |
|
GRTX
Galera Therapeutics
|
Aug 17, 2023 | HOLD |
Buy
+6826.8% avg upside
7 analysts
|
$0.50
488.29% Upside
|
· |
|
ATYR
aTyr Pharma
|
Apr 11, 2023 | BUY |
Buy
+2016.8% avg upside
17 analysts
|
$13.00
2708.40% Upside
|
-11.6% |
|
INFIQ
Infinity Pharmaceuticals
|
Feb 23, 2023 | HOLD |
Buy
+647142757.1% avg upside
8 analysts
|
$0.30
29999900.00% Upside
|
-100.0% |
|
SYRE
Spyre Therapeutics
|
Oct 27, 2022 | BUY |
Strong Buy
-15.4% avg upside
23 analysts
|
$37.50
57.14% Downside
|
· |
|
PRTCY
PureTech Health
|
Aug 25, 2022 | BUY |
Strong Buy
+194.2% avg upside
3 analysts
|
$44.00
153.75% Upside
|
· |
|
APVO
Aptevo Therapeutics
|
Aug 12, 2022 | BUY |
Strong Buy
+163.1% avg upside
4 analysts
|
$13.00
170.77% Upside
|
-89.4% |
|
ELOX
Eloxx Pharmaceuticals
|
May 23, 2022 | BUY |
Strong Buy
+153.9% avg upside
8 analysts
|
$60.00
328.64% Upside
|
-37.8% |
|
KLDO
Kaleido Biosciences
|
Jan 30, 2022 | BUY |
Buy
+13249900.0% avg upside
5 analysts
|
$4.00
3999900.03% Upside
|
· |
|
VRTX
Vertex Pharmaceuticals
|
Oct 18, 2021 | BUY |
Strong Buy
-2.7% avg upside
61 analysts
|
$323.00
29.58% Downside
|
+66.0% |
|
SYBX
Synlogic
|
Sep 20, 2021 | BUY |
Buy
+3290.3% avg upside
11 analysts
|
$9.00
1167.65% Upside
|
-72.2% |
|
CYTK
Cytokinetics
|
Aug 08, 2021 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$40.00
48.70% Downside
|
+67.9% |
|
EXEL
Exelixis
|
Jun 28, 2021 | BUY |
Strong Buy
-21.1% avg upside
33 analysts
|
$36.00
31.36% Downside
|
+16.2% |
|
ARGX
Argenx Se
|
Jun 07, 2021 | HOLD |
Strong Buy
-15.8% avg upside
46 analysts
|
$250.00
71.94% Downside
|
+25.1% |
|
GB:0QW0
arGEN X
|
Feb 04, 2021 | HOLD |
Strong Buy
-23.2% avg upside
24 analysts
|
$266.08
65.36% Downside
|
· |
|
MTNB
Matinas BioPharma
|
Jun 30, 2020 | BUY |
Buy
+2183.8% avg upside
7 analysts
|
$1.50
111.20% Upside
|
+0.3% |
|
MRKR
Marker Therapeutics
|
May 12, 2020 | HOLD |
Strong Buy
+994.1% avg upside
9 analysts
|
$2.50
85.22% Upside
|
-8.5% |
|
GILD
Gilead Sciences
|
Mar 20, 2020 | BUY |
Strong Buy
-4.8% avg upside
66 analysts
|
$90.00
28.27% Downside
|
-8.2% |
|
CFRXQ
ContraFect
|
Dec 11, 2019 | BUY |
Buy
+10969999900.0% avg upside
10 analysts
|
$10.00
999999899.98% Upside
|
· |
|
LRMR
Larimar Therapeutics
|
Sep 05, 2019 | HOLD |
Strong Buy
+413.5% avg upside
21 analysts
|
$60.00
1594.85% Upside
|
+45.8% |
|
SRPT
Sarepta Therapeutics
|
Jun 21, 2019 | BUY |
Buy
+246.5% avg upside
49 analysts
|
$208.00
1126.39% Upside
|
+30.0% |
|
BAYRY
Bayer
|
Jun 04, 2019 | BUY |
Buy
+293.3% avg upside
9 analysts
|
$32.00
198.71% Upside
|
+21.6% |
|
NVAX
Novavax
|
Feb 28, 2019 | SELL |
Buy
+154.0% avg upside
20 analysts
|
$5.00
47.31% Downside
|
-12.7% |
|
ONCSQ
OncoSec Medical
|
Dec 12, 2018 | BUY |
Strong Buy
+4699999900.0% avg upside
9 analysts
|
$30.00
2999999899.99% Upside
|
· |
|
VCEL
Vericel
|
Nov 06, 2018 | BUY |
Strong Buy
+14.1% avg upside
16 analysts
|
$19.00
51.37% Downside
|
+12.6% |
|
VTAK
Catheter Precision
|
Oct 22, 2018 | BUY |
Buy
+2677.9% avg upside
5 analysts
|
$23.00
2320.99% Upside
|
-87.8% |
|
ANTH
Anthera Pharmaceuticals
|
Mar 12, 2018 | SELL |
Buy
+472857042.9% avg upside
9 analysts
|
$0.10
9999899.92% Upside
|
· |
|
GNCAQ
Genocea Biosciences
|
Nov 02, 2017 | BUY |
Strong Buy
+573999900.0% avg upside
10 analysts
|
$5.00
499999899.95% Upside
|
· |
|
REGN
Regeneron
|
Sep 11, 2017 | BUY |
Strong Buy
+26.9% avg upside
57 analysts
|
$557.00
8.37% Downside
|
-11.5% |
|
VIVS
VivoSim Labs
|
Feb 09, 2017 | BUY |
Buy
+156.6% avg upside
5 analysts
|
$4.00
254.02% Upside
|
-67.4% |
|
SVRA
Savara
|
Sep 07, 2016 | BUY |
Strong Buy
+58.2% avg upside
17 analysts
|
$1.00
81.38% Downside
|
-26.4% |
|
DAL
Delta Air Lines
|
Aug 18, 2016 | BUY |
Strong Buy
-10.3% avg upside
30 analysts
|
$35.00
57.42% Downside
|
+29.8% |
|
XOMA
XOMA Royalty Corporation
|
Mar 10, 2016 | HOLD |
Buy
-46.4% avg upside
11 analysts
|
— | -68.5% |
|
ATHXQ
Athersys
|
Jul 09, 2015 | HOLD |
Buy
+29964185.8% avg upside
8 analysts
|
$1.00
999900.05% Upside
|
+99.1% |
|
IONS
Ionis Pharmaceuticals
|
Jul 23, 2013 | SELL |
Strong Buy
+13.3% avg upside
43 analysts
|
$20.00
73.04% Downside
|
-7.8% |
|
ONCY
Oncolytics Biotech
|
Mar 04, 2013 | BUY |
Strong Buy
+654.5% avg upside
12 analysts
|
$6.00
544.00% Upside
|
-49.0% |
|
CRIS
Curis
|
Feb 20, 2013 | BUY |
Strong Buy
+1938.0% avg upside
12 analysts
|
$6.00
1377.82% Upside
|
+13.5% |
|
SLS
SELLAS Life Sciences Group
|
Dec 31, 2012 | BUY |
Strong Buy
+768.3% avg upside
15 analysts
|
$2.50
67.87% Downside
|
+224.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.